Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pre Market Bid .0007 Ask .0008 EOM
Your comments are really not correct. There were many more buys than sells today. Also, if we have no revenue producing assets, how were we able to give up part of our oil interests for a SOMA dividend which appears to be worth millions? Those dividends may not be generating any income for the EQBM but they certainly will generate income for the EQBM shareholders. Assuming 400M EQBM O/S divides by 50 (1 share od SOMA for 50 shares of EQBM)is 8 million in SOMA shares for the EQBM shareholders. Ignoring the warrant, if these SOMA shares end up being worth 50 cents that equates to $4 million or 1 cents of value (income) to each shareholder. If you do not think that is income, may I please have your dividends. Please don't be so negative.
By my estimate, of the 7.5 million shares traded today about 90 percent were buys and 10 percent were sells. If the MMs were trying to cut into any short position, they were not very successful.
Big trade after market close -700,000 shares at .0106
0.0106 700000 OTO 16:12:16
0.01 140000 OTO 15:48:07
0.01 2000 OTO 15:46:53
0.01 58802 OTO 15:32:20
0.01 30000 OTO 15:30:50
0.009 67000 OTO 15:30:40
0.01 50000 OTO 15:29:32
0.01 22000 OTO 15:22:50
0.01 25000 OTO 15:21:40
0.01 169984 OTO 15:20:49
0.01 400000 OTO 15:20:19
0.01 75000 OTO 15:20:10
0.0105 25000 OTO 15:04:57
0.01 290 OTO 14:32:45
0.01 289000 OTO 14:21:19
0.01 100000 OTO 14:12:02
0.0105 50000 OTO 13:59:40
0.011 50000 OTO 13:59:40
0.01 186000 OTO 12:33:06
0.01 40000 OTO 12:33:06
0.01 123076 OTO 12:33:06
0.0105 77000 OTO 12:32:14
0.011 77000 OTO 12:32:14
0.01 100000 OTO 11:39:32
0.01 100000 OTO 11:18:43
0.0093 50000 OTO 11:16:46
0.01 5000 OTO 11:15:19
0.01 10000 OTO 11:13:53
0.009 112266 OTO 11:12:08
0.01 112266 OTO 11:12:08
DrFeelgood, you are a long way from the NNVC board. However, stick around for the fun that should follow. Maybe you can help to jumpstart EQBM. Welcome.
In case you do not have access to Level 2, here are the last trades of the day for EQBM:
0.0102 666 OTO 15:59:47
0.0086 64300 OTO 15:59:15
0.0102 500 OTO 15:59:14
0.009 10000 OTO 15:59:02
0.0102 15000 OTO 15:58:58
0.014 5000 OTO 15:58:50
0.01 51150 OTO 15:56:37
0.0105 50000 OTO 15:56:37
0.011 200000 OTO 15:56:37
0.0102 3000 OTO 15:44:44
0.0102 4000 OTO 15:42:29
0.0098 115000 OTO 15:30:47
0.01 21000 OTO 15:29:50
0.01 12160 OTO 15:29:50
0.0095 12160 OTO 15:29:50
0.0095 14034 OTO 15:29:45
0.0095 100000 OTO 15:29:36
0.009 50000 OTO 15:18:27
0.009 50000 OTO 15:18:24
0.009 70000 OTO 15:17:12
0.0095 50000 OTO 15:07:31
0.0095 100000 OTO 15:01:49
0.0095 9200 OTO 14:59:09
0.0095 80000 OTO 14:58:28
0.0095 3000 OTO 14:57:47
0.0095 187340 OTO 14:51:22
0.0093 50000 OTO 14:43:20
0.01 187000 OTO 14:43:20
0.01 15000 OTO 14:41:05
0.0093 2000 OTO 14:22:59
Press Release Source: Equitable Mining Corp.
Equitable Mining Corp. (EQUITABLE) asset sale to Soma Petroleum Limited (SOMA) results in share dividend
Monday November 13, 1:53 pm ET
CHEYENNE, WY, Nov. 13 /PRNewswire-FirstCall/ - Equitable Mining Corp. (EQUITABLE), a resource company trading as EQBL on PinkSheets.com and E5W on the Frankfurt Exchange, is selling assets to Soma Petroleum Limited (SOMA) an oil and gas resource company in exchange for SOMA shares.
ADVERTISEMENT
This is being done to enable EQUITABLE to partner with SOMA in joint ventures worldwide. SOMA has far reaching connections and partnerships in the African market. EQUITABLE is selling fifty percent of its oil and gas leaseholds in Somaliland (East Africa) in exchange for cash and marketable securities.
The company, will in turn, issue as a dividend the shares it owns in SOMA to EQUITABLE shareholders on record as of November 24, 2006. The shares will be distributed as a special unit containing one share of SOMA and a warrant to purchase an additional share at $0.78 USD for every fifty shares of EQUITABLE. The warrant has an expiry date of December 24, 2006.
Details on the dividend transfer and the warrant issue will be released later this week.
"This transaction will allow EQUITABLE shareholders to realize value in the company's assets," said Mr. Lawrence Skolnik, EQUITABLE President.
About EQUITABLE
Equitable Mining Corporation is a rapidly expanding company focused on acquiring, exploring, developing and extracting mineral rights worldwide. Projects include the Bonanza Property in Canada's high-yield Red Lake Gold Camp, an acquisition in progress in Colombia, a memorandum of understanding for a precious metals mine in China, and ongoing acquisition programs in mineral-rich areas of North America, South America and Australasia. The company is leveraging its deep industry expertise and extensive contacts to recruit mining industry veterans and expand its search for quality gold and other precious metals-bearing properties in the Americas and Australasia. For more information visit www.equitablelifeinvestments.com.
About SOMA PETROLEUM
SOMA is a US registered corporation that has interests in old and gas projects in the Horn of Africa. It has partnered with leading resources developers including Inter-Continental Petroleum Co. Ltd (ICPC), a China-based oil and gas exploration company. ICPC has an extensive international track record in oil and gas. www.somapetroleum.com
Information presented in this newsletter contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects'", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur.
Source: Equitable Mining Corp.
MMs mess with the Bid price all the time. They will lower it to see if they can pick up cheap shares. Below are all the trades in stock today so far. As it indicates there is no wacking going on:
0.0074 10000 OTO 14:04:00
0.0065 10000 OTO 14:03:55
0.0065 120000 OTO 14:03:51
0.0074 50000 OTO 14:01:24
0.007 50000 OTO 14:01:19
0.0071 30000 OTO 14:01:17
0.007 125000 OTO 13:47:34
0.007 100000 OTO 13:15:24
0.007 100000 OTO 13:15:24
0.007 55000 OTO 13:00:57
0.007 45000 OTO 12:27:11
0.0075 50000 OTO 11:08:20
0.0073 47000 OTO 11:08:20
0.007 20000 OTO 10:58:33
0.007 60800 OTO 10:57:12
0.007 89000 OTO 10:05:10
0.007 10000 OTO 10:05:06
0.007 36000 OTO 10:01:27
0.007 36000 OTO 10:01:27
0.007 100000 OTO 10:01:27
0.007 200000 OTO 09:38:27
0.007 208000 OTO 09:38:22
0.007 41000 OTO 09:30:23
Today, there were 1.53 million shares of EQBM traded; 1,225,000 at the asked - .007, 300,000 at .0065 and 5,000 shares at .006. In spite of the preponderance of shares sold at the asked, the MMs to my knowledge never raised the Asked above .007 all day. Yesterday's results were similar. Looks like MMs are deliberately holding the price down. I am new to this board and have been buying shares over the past few weeks. As has been indicated many times here, the combination of dividend, news and Frankfurd exchange may be the winning trifecta for EQBM.
I can appreciate where you are comming from with your comments. Most Corporate Presidents like Mr. Downs do not have the technical skills to come up with the great new technology. That is why they have employees. Mr. Downs obviously is a visionary with a great staff to come up with the technology thay IDWD now possesses. As for the Press Releases, I have a theory. Mr. Downs has been told time after time through message boards etc that his PRs are seriously lacking. If he wanted he could hire someone to make them much better. However, he elects not to and continues on with the same old crappy press releases. My thought is that this is intentional. He puts out the news in a somewhat timely fashion to the public, so that he cannot be accused of not keeping the public informed. However, the news is written in such a way that no one is going to take what he has to say too seriously. Thus, he is able to get the news out but it has little effect on the PPS. No one can come back later and blame him for not keeping the public informed. How well the PRs were written will be immaterial. However, the price of the shares stays low and HSM is able to buy the cheap shares. Naturally, I could be wrong but these are my opinions.
To the contrary, my thinking appears to be just the opposite of yours. I feel very strongly that the buyout will occur and HLS will go on to do great things. What we do have in common is a less than favorable opinion of IDWD's press releases. Todate, they have been less than informative, always late, vague, confusing, creating more questions than answers, grammatically incorrect, frustrating and I could go on and on about them. The good news is that after the buyout, Mr. Downs will no longer be a Director and will no longer write the Press Releases. Finally, there will no longer be a convicted felon as an officer and you guys can go spread your venom elsewhere.
You have made this post several times before. If all the shares are in the hands of insiders, that means the insiders are hanging on to the shares because they have a strong belief in the Company based on the inside information they possess. If the insiders did not have the majority of shares then I would worry. What is your point?
You buzzards on this board are pathetic. My guess is that you are spending your day awaiting the press release on the slim chance you have all been wrong and to buy if you can find some verifiable DD. Poor losers.
Penny,
Is it true what they are saying about you on the HSM board? Does that explain your fixation about the age of some of the posters on these boards? Hopefully, the buyout of IDWD will be completed soon and you and your croonies here can move on and torment some other board.
I agree you are always on the ball. You may have slipped but you certainly did not fall off. We appreciate all the DD you provide to this board. Keep up the good work.
All is quiet on the HSM Board. The longs there know what thay have. They are not trying to convince anyone of anything. Just the opposite here. This is the bashers last stand. Why else would they waste there time on a busy weekend of football and playoff games to bash here. Who are they really trying to help? They have already made over 40 posts here this weekend and still going strong. By the way Penny Cow, is a lying insecure individual. He asked me a bunch of stupid questions and started cursing when I would not answer them. He needs to calm down. He is really intense. He seems to thing that because some goofy picture on a websight looks bogus to him that the Buy Out will not go through. He thinks that is DD. What a joke. Penny, please do not call me anymore.
CYBU - I have seen the question asked several times on this board as to the number of issued and outstanding shares. But I have never seen a direct answer only something about a reverse split. Please, can you or anyone tell me the number of issued and outstanding shares? Also, can anyone tell me about what the annual revenues were for the last 12 months? I called the company Friday and asked how many shares were issued and outstanding. They would not tell me. All they would say was that they were working on their financials and hoped to file soon and get on a higher board. The only other things they would say were that (i)PDSC was DEBT FREE which I thought was a strong positive considering how poorly the stock has been acting and (ii)there has been a lot of shorting going on with the stock.
CYBU - I have seen the question asked several times on this board as to the number of issued and outstanding shares. But I have never seen a direct answer only something about a reverse split. Please, can you or anyone tell me the number of issued and outstanding shares? Also, can anyone tell me about what the annual revenues were for the last 12 months? I called the company Friday and asked how many shares were issued and outstanding. They would not tell me. All they would say was that they were working on their financials and hoped to file soon and get on a higher board. The only other things they would say were that (i)PDSC was DEBT FREE which I thought was a strong positive considering how poorly the stock has been acting and (ii)there has been a lot of shorting going on with the stock.
CYBU - I have seen the question asked several times on this board as to the number of issued and outstanding shares. But I have never seen a direct answer only something about a reverse split. Please, can you or anyone tell me the number of issued and outstanding shares? Also, can anyone tell me about what the annual revenues were for the last 12 months? I called the company Friday and asked how many shares were issued and outstanding. They would not tell me. All they would say was that they were working on their financials and hoped to file soon and get on a higher board. The only other things they would say were that (i)PDSC was DEBT FREE which I thought was a strong positive considering how poorly the stock has been acting and (ii)there has been a lot of shorting going on with the stock.
MM=Market Maker
He has a lot more creditability than you do. IMO
Did anyone ever figure out what NYOM DOES?
Here is the best recommendation I can make to you. Buy IDWD. Don't ask me for the DD crap, just do it. You never said what happened to the other stock.
No luck. What ever happened on the buy out of the other deal you were looking at - fhal? Did it happen?
I should have pulled the trigger on your KING recommendation. Great call. Hope you are as right with IDWD.
Todays low so far is .014. MMs are olaying games with a Bid of .013 and an asked of .014. They are looking for cheap stock.
There are different Flexogen products. Each type may have a different smell. The one I have used is the Flexogan Sports ULTRA/Ultra Phyto. It definitely smells like BenGay.
10 M here
AAGM will be going UP in price soon. Whether there is 500 or 600 Million shares outstanding is immaterial at these prices. The market cap at .001 is currently only $500,000 or 600,000. A pink sheet shell is worth around $1 to $1.2 million. Therefore, if AAGM does nothing it is worth at least .002 as a shell. However, AAGM is worth much more than a shell. It has products that are and will be great. I can personally only speak about Flexogan. I ordered it from the AAGM website, received it about 1 week later, tried it and it works great. Smells just like BenGay but is seems to be more effective in reducing aches and pains in your joints. Once AAGM has a chance to conclude its distributorship arrangements, the price will go up. In the meantime, stop all this meaningless chatter everytime AAGM goes up or down a fraction. If you see it selling at .001 to .002 you should be quiet and be loading up instead of complaining. When the stock has a market cap of $10 million and selling for 2 cents a share, the current price of the stock be it .001 or .0013 will be a distant memory. For now just enjoy the buying opportunities that the people who sold AAGM their shell have given you by selling their shock so cheap.
Press Release Source: NanoViricides, Inc.
NanoViricides, Inc. Preparing to Release Financials and File With SEC
Tuesday August 1, 7:05 am ET
WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 1, 2006--NanoViricides, Inc. (Pink Sheets:NNVC - News), announced today that it is very close to releasing the financial data for the June 30, 2006 year end.
ADVERTISEMENT
click here
The Company's CEO, Eugene Seymour, MD, MPH stated, "the Company has received numerous inquiries from its stockholders and others as to when we will release our financial data and complete the SEC filing to become a fully reporting company. We are now very close to accomplishing both of these objectives."
The Company also updated its shareholders as to the status of its financial audit. Mr. Leo Ehrlich, CFO, announced that "the Company's financial statements for our fiscal year end, June 30, 2006, have already been forwarded to our auditors, Holtz Rubenstein Reminick LLP. The auditors have sent out the confirmation requests and the audit review is in progress. We are now preparing for releasing the financials after a preliminary approval by the auditors."
The Company had intended to file with the SEC in 2005; however a discrepancy was found in the number of common stock shares claimed by certain earlier stockholders, resulting in a delay.
"The Company took decisive action and had the shares in question canceled, an outcome with a significant benefit to our shareholders. We are now focused on becoming an SEC reporting company," Mr. Ehrlich added further.
Mr. Ehrlich, continued, "In this week's edition of Barron's, there appears an interview with Dean LeBaron, Chairman of Virtualquest. Mr. LeBaron comments that 'Bird flu is likely to arrive in the United States before the end of the year' and on another question responds 'essentially we are very close to the breaking point where there is a particular class and set of drugs that will deliver individually targeted treatments and hopefully will revolutionize medicine.' I believe his opinions are representative of a significant number of fund managers. Once we become a reporting company, NanoViricides stock will be available for investment to a huge pool of potential new stockholders, including funds and institutional investors. This will help in funding the Company's facilities and drug development activities."
The Company continues to receive a number of questions from its stockholders at our email info@nanoviricides.com. We will attempt to answer them in forthcoming press releases.
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
Contact:
NanoViricides, Inc.
Leo Ehrlich, 917-853-6440
leo@nanoviricides.com
Source: NanoViricides, Inc.
Click Here $7 TRADES!
Press Release Source: NanoViricides, Inc.
NanoViricides, Inc. Preparing to Release Financials and File With SEC
Tuesday August 1, 7:05 am ET
WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 1, 2006--NanoViricides, Inc. (Pink Sheets:NNVC - News), announced today that it is very close to releasing the financial data for the June 30, 2006 year end.
ADVERTISEMENT
click here
The Company's CEO, Eugene Seymour, MD, MPH stated, "the Company has received numerous inquiries from its stockholders and others as to when we will release our financial data and complete the SEC filing to become a fully reporting company. We are now very close to accomplishing both of these objectives."
The Company also updated its shareholders as to the status of its financial audit. Mr. Leo Ehrlich, CFO, announced that "the Company's financial statements for our fiscal year end, June 30, 2006, have already been forwarded to our auditors, Holtz Rubenstein Reminick LLP. The auditors have sent out the confirmation requests and the audit review is in progress. We are now preparing for releasing the financials after a preliminary approval by the auditors."
The Company had intended to file with the SEC in 2005; however a discrepancy was found in the number of common stock shares claimed by certain earlier stockholders, resulting in a delay.
"The Company took decisive action and had the shares in question canceled, an outcome with a significant benefit to our shareholders. We are now focused on becoming an SEC reporting company," Mr. Ehrlich added further.
Mr. Ehrlich, continued, "In this week's edition of Barron's, there appears an interview with Dean LeBaron, Chairman of Virtualquest. Mr. LeBaron comments that 'Bird flu is likely to arrive in the United States before the end of the year' and on another question responds 'essentially we are very close to the breaking point where there is a particular class and set of drugs that will deliver individually targeted treatments and hopefully will revolutionize medicine.' I believe his opinions are representative of a significant number of fund managers. Once we become a reporting company, NanoViricides stock will be available for investment to a huge pool of potential new stockholders, including funds and institutional investors. This will help in funding the Company's facilities and drug development activities."
The Company continues to receive a number of questions from its stockholders at our email info@nanoviricides.com. We will attempt to answer them in forthcoming press releases.
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
Contact:
NanoViricides, Inc.
Leo Ehrlich, 917-853-6440
leo@nanoviricides.com
Source: NanoViricides, Inc.
This PR just out should get things moving up again.
Press Release Source: NanoViricides, Inc.
NanoViricides, Inc. Addresses Shareholders on GSK Bird Flu Vaccine
Monday July 31, 7:30 am ET
NanoViricides, Inc., expects billion dollar plus annual market for its influenza drugs
WEST HAVEN, Conn.--(BUSINESS WIRE)--July 31, 2006--Anil Diwan, PhD, NanoViricides' (Pink Sheets: NNVC - News) President, today commented that, "The GSK vaccine has shown significantly better efficacy than the previous vaccines. The GSK vaccine showed an 80% protection in treated individuals. This is still far less than the 95% or better usual clinical protection level of annual influenza vaccines. Using the 80% protection rate, approximately 50% of the population may be expected to show H5N1 bird flu pathology even if a vaccine campaign with the GSK vaccine covered 100% of the world population. The high rates of emergence of resistant viral mutants with existing and developing neuraminidase inhibitor therapies such as Tamiflu(TM), Relenza(TM), or Peramivir(TM), make these therapies unsuitable for widespread strategic use in pandemic containment. In contrast, pre-clinical studies lead us to believe that most of such patients would be curable with our experimental anti-influenza nanoviricides drugs; AviFluCide(TM)-I and FluCide(TM)-I."
ADVERTISEMENT
click here
The Company's CEO, Eugene Seymour, MD, MPH stated, "It is estimated that over 50 million people in the US and Western Europe become clinically ill with human influenza year after year, despite a strong and effective annual vaccine campaign. Approximately 60,000 deaths occur from common influenza annually within the US and Europe alone. We estimate a multi-billion dollar market for our influenza drugs FluCide(TM) and AviFluCide(TM), drugs which early results can be described as a revolution in medicine."
Other announcements by NanoViricides Inc.:
* Dr. Diwan will be speaking at the Novel Vaccines Conference in August in Boston, MA. The vaccine scientific community has shown a particularly strong interest in the nanoviricides(TM) technology and their ability to rapidly create nanoviricides against emerging threats. There is a deep understanding within the scientific community that vaccines and targeted treatments are the two critically important tools for solving the challenge that a virus presents.
* Additional information will be released to its shareholders over the coming weeks.
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
Contact:
NanoViricides, Inc.
Leo Ehrlich, 917-853-6440
leo@nanoviricides.com
Source: NanoViricides, Inc.
No, looks like there would be just too much trouble in buying a restricted stock from amother person. The red tape in buying restricted shares from a Company is a lot but the headaches would be much worse in trying to sell restricted stock bought from an individual. If anyone has done it (bought restricted shares from an individual) and been able to resale them, I would sure like to know how the restriction got removed to be resold.
This looks exciting. I see that the combined two companies have 62 Million shares outstanding. Correct? Do we know what the annual sales and net income has been for a recent 12 month period? Also, do we know the number of stock options that are out there? Any answer would be most appreciated.
I have been trying to think through this 144 two year hold vs SB-2 where the shares can be immediately registered for sale. I have been involved in both types of situations before. In the SB-2 SEC filing, I believe the names of all the shareholders who received the stock dividend in HLS Worldwide must be included in the Prospectus in order to have the restriction removed from their certificate. That would be easy to do if all the names of the individuals who received the dividends were known. However, probably most of the individuals are nameless and have there shares in street name like mine at Scottrade. I am not sure how HLS Worldwide would be able to come up with our names to include in a SB-2 filing. Without the SB-2 filing we would have to hold the shares for at least the 2 year period. Do you (or anybody) have any answers to my perceived problem in getting our names included in the SB-2? Thanks.
Also, the perceived problem outlined above is compounded if someone tries to sell his restricted shares at a discount to another individual before the SB-2 filing. If your name in not included in the SB-2 filing for those restricted shares that you purchased from another individual, you may never be able to get the restriction removed. Any answers would be appreciated. I have offered to purchase some of these restricted shares from others. However, because of the problems mentioned above this purchase of restricted shares may not be feasable.
thisdoesnotwork - Please give me a call Saturday around 1000am CDT and we can discuss. My phone # is 314-494-6661.
HLS Worldwide Restricted Shares in SCOTTRADE Account - If you are fed up waiting for your HLS Worldwide shares to begin publiclly trading and want out, I will buy your shares. They can be easily transferred from your SCOTTRADE Account to mine and I will transfer cash back into your account. However, you must be willing to sell them in the .10 to .25 cent per share price range. Turn those worthless restricted shares into instant cash. It may be years, if ever, before the restricted shares become tradable. If interested, please let me know.
HLS Worldwide Restricted Shares in SCOTTRADE Account - If you are fed up waiting for your HLS Worldwide shares to begin publiclly trading and want out, I will buy your shares if they can be easily transferred from your SCOTTRADE Account to mine. However, you must be willing to sell them for in the .10 to .25 cent per share price range. If interested let me know.
How many shares do you have and do you have a Scottrade Account?
I have one and it would make it much easier to transfer the shares.
Limoguy! You are not doing your job in keeping us posted here. Current Bid $1.03 Current Ask $1.05. Okay, now that I got you started, you can resume keeping us posted from here. Keep up the good work.